---

A-Bio has invested RM7 million (US$1.8M) in Clinipath Malaysia Sdn Bhd (Clinipath) as part of the efforts of both companies to catalyse the digitalization of the healthcare industry in Malaysia. Clinipath, wholly owned by Malaysian Genomics Resource Centre Berhad (Malaysian Genomics), is one of Malaysia’s leading pathology service providers with a nationwide network of clinical laboratories serving doctors in hospitals, clinics and research laboratories.

Read more at Deal Street Asia